Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bioventus Inc.

7.34
+0.08001.10%
Post-market: 7.14-0.2000-2.72%16:10 EDT
Volume:377.95K
Turnover:2.78M
Market Cap:486.13M
PE:-14.12
High:7.55
Open:7.38
Low:7.30
Close:7.26
Loading ...
Jun 17, 2024

Major Issues Report

Form 8-K - Current report
May 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 07, 2024

Major Issues Report

Form 8-K - Current report
Apr 11, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 11, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 11, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 28, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 26, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 20, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 12, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 12, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 06, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 23, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 19, 2024

Major Issues Report

Form 8-K - Current report
Jan 12, 2024

Major Issues Report

Form 8-K - Current report
Jan 09, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Dec 21, 2023

Major Issues Report

Form 8-K - Current report
Nov 07, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 07, 2023

Major Issues Report

Form 8-K - Current report